DHI Historical Income Statement

DHI Stock

USD 145.88 0.14 0.1%

Historical analysis of DR Horton income statement accounts such as Selling General Administrative of 3.9 B or Total Revenue of 42.8 B can show how well DR Horton performed in making a profits. Evaluating DR Horton income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of DR Horton's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining DR Horton latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DR Horton is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.

About DHI Income Statement Analysis

DR Horton Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to DR Horton shareholders. The income statement also shows DHI investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

DR Horton Income Statement Chart

DR Horton Income Statement is one of the three primary financial statements used for reporting DHI's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of DR Horton revenue and expense. DR Horton Income Statement primarily focuses on the company's revenues and expenses during a particular period.

As of now, DR Horton's Total Revenue is increasing as compared to previous years. The DR Horton's current Gross Profit is estimated to increase to about 11.3 B, while Extraordinary Items is forecasted to increase to (92.9 M).

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses

Total Revenue

Total revenue comprises all receipts DR Horton generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of DR Horton minus its cost of goods sold. It is profit before DR Horton operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of DR Horton. It is also known as DR Horton overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from DR Horton's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into DR Horton current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.As of now, DR Horton's Total Revenue is increasing as compared to previous years. The DR Horton's current Gross Profit is estimated to increase to about 11.3 B, while Extraordinary Items is forecasted to increase to (92.9 M).

	2021	2022	2023	2024 (projected)
Gross Profit	10.5B	9.4B	10.8B	11.3B
Total Revenue	33.5B	35.5B	40.8B	42.8B

Gross Profit Total Revenue

DR Horton income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Extraordinary Items	Net Income From Continuing Ops	Non Operating Income Net Other	Selling And Marketing Expenses	Non Recurring	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.72	0.95	0.94	0.9	0.95	0.86	0.86	0.86	0.95	0.96	0.86	0.82	0.84	0.88	-0.44	0.83	0.84	0.75	-0.79	0.0	0.71	0.8	0.8	0.83
Interest Expense	0.72		0.73	0.71	0.65	0.73	0.62	0.61	0.61	0.73	0.73	0.62	0.85	0.63	0.56	-0.14	0.63	0.59	0.36	-0.42	0.24	0.46	0.71	0.71	0.77
Selling General Administrative	0.95	0.73		1.0	0.98	1.0	0.96	0.96	0.96	1.0	1.0	0.96	0.84	0.95	0.94	-0.33	0.95	0.88	0.64	-0.64	-0.19	0.84	0.85	0.85	0.89
Total Revenue	0.94	0.71	1.0		0.99	1.0	0.98	0.97	0.98	1.0	1.0	0.98	0.83	0.97	0.95	-0.28	0.96	0.88	0.6	-0.62	-0.22	0.86	0.84	0.84	0.9
Gross Profit	0.9	0.65	0.98	0.99		0.98	1.0	1.0	1.0	0.98	0.98	1.0	0.77	0.99	0.96	-0.24	0.99	0.86	0.56	-0.58	-0.26	0.9	0.8	0.8	0.89
Other Operating Expenses	0.95	0.73	1.0	1.0	0.98		0.97	0.96	0.96	1.0	1.0	0.97	0.85	0.95	0.94	-0.3	0.95	0.88	0.62	-0.64	-0.2	0.84	0.85	0.85	0.9
Operating Income	0.86	0.62	0.96	0.98	1.0	0.97		1.0	1.0	0.97	0.96	1.0	0.75	0.99	0.95	-0.2	0.99	0.85	0.51	-0.54	-0.31	0.92	0.78	0.78	0.88
Ebit	0.86	0.61	0.96	0.97	1.0	0.96	1.0		1.0	0.96	0.96	1.0	0.73	0.99	0.95	-0.21	0.99	0.84	0.51	-0.54	-0.3	0.92	0.77	0.77	0.87
Ebitda	0.86	0.61	0.96	0.98	1.0	0.96	1.0	1.0		0.96	0.96	1.0	0.73	0.99	0.95	-0.21	0.99	0.84	0.52	-0.55	-0.29	0.92	0.78	0.78	0.87
Cost Of Revenue	0.95	0.73	1.0	1.0	0.98	1.0	0.97	0.96	0.96		1.0	0.97	0.85	0.95	0.94	-0.29	0.95	0.88	0.62	-0.64	-0.2	0.84	0.85	0.85	0.9
Total Operating Expenses	0.96	0.73	1.0	1.0	0.98	1.0	0.96	0.96	0.96	1.0		0.96	0.84	0.95	0.94	-0.33	0.95	0.88	0.64	-0.64	-0.19	0.84	0.85	0.85	0.89
Income Before Tax	0.86	0.62	0.96	0.98	1.0	0.97	1.0	1.0	1.0	0.97	0.96		0.75	0.99	0.95	-0.2	0.99	0.85	0.52	-0.55	-0.29	0.92	0.78	0.78	0.88
Total Other Income Expense Net	0.82	0.85	0.84	0.83	0.77	0.85	0.75	0.73	0.73	0.85	0.84	0.75		0.74	0.71	-0.12	0.74	0.8	0.44	-0.43	0.08	0.59	0.82	0.82	0.88
Net Income	0.84	0.63	0.95	0.97	0.99	0.95	0.99	0.99	0.99	0.95	0.95	0.99	0.74		0.92	-0.21	1.0	0.84	0.45	-0.51	-0.28	0.92	0.77	0.77	0.88
Income Tax Expense	0.88	0.56	0.94	0.95	0.96	0.94	0.95	0.95	0.95	0.94	0.94	0.95	0.71	0.92		-0.18	0.92	0.82	0.68	-0.63	-0.29	0.86	0.77	0.77	0.82
Extraordinary Items	-0.44	-0.14	-0.33	-0.28	-0.24	-0.3	-0.2	-0.21	-0.21	-0.29	-0.33	-0.2	-0.12	-0.21	-0.18		-0.18	-0.25	-0.62	0.41	-0.1	-0.16	-0.13	-0.13	-0.15
Net Income From Continuing Ops	0.83	0.63	0.95	0.96	0.99	0.95	0.99	0.99	0.99	0.95	0.95	0.99	0.74	1.0	0.92	-0.18		0.84	0.44	-0.5	-0.29	0.92	0.77	0.77	0.88
Non Operating Income Net Other	0.84	0.59	0.88	0.88	0.86	0.88	0.85	0.84	0.84	0.88	0.88	0.85	0.8	0.84	0.82	-0.25	0.84		0.53	-0.56	-0.14	0.74	0.79	0.79	0.82
Selling And Marketing Expenses	0.75	0.36	0.64	0.6	0.56	0.62	0.51	0.51	0.52	0.62	0.64	0.52	0.44	0.45	0.68	-0.62	0.44	0.53		-0.65	0.02	0.38	0.48	0.48	0.43
Non Recurring	-0.79	-0.42	-0.64	-0.62	-0.58	-0.64	-0.54	-0.54	-0.55	-0.64	-0.64	-0.55	-0.43	-0.51	-0.63	0.41	-0.5	-0.56	-0.65		-0.13	-0.46	-0.51	-0.51	-0.49
Minority Interest	0.0	0.24	-0.19	-0.22	-0.26	-0.2	-0.31	-0.3	-0.29	-0.2	-0.19	-0.29	0.08	-0.28	-0.29	-0.1	-0.29	-0.14	0.02	-0.13		-0.36	-0.09	-0.09	-0.02
Tax Provision	0.71	0.46	0.84	0.86	0.9	0.84	0.92	0.92	0.92	0.84	0.84	0.92	0.59	0.92	0.86	-0.16	0.92	0.74	0.38	-0.46	-0.36		0.72	0.72	0.87
Net Interest Income	0.8	0.71	0.85	0.84	0.8	0.85	0.78	0.77	0.78	0.85	0.85	0.78	0.82	0.77	0.77	-0.13	0.77	0.79	0.48	-0.51	-0.09	0.72		1.0	0.86
Interest Income	0.8	0.71	0.85	0.84	0.8	0.85	0.78	0.77	0.78	0.85	0.85	0.78	0.82	0.77	0.77	-0.13	0.77	0.79	0.48	-0.51	-0.09	0.72	1.0		0.86
Reconciled Depreciation	0.83	0.77	0.89	0.9	0.89	0.9	0.88	0.87	0.87	0.9	0.89	0.88	0.88	0.88	0.82	-0.15	0.88	0.82	0.43	-0.49	-0.02	0.87	0.86	0.86

Click cells to compare fundamentals

DR Horton Account Relationship Matchups

DR Horton income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	80.4M	73.9M	81.4M	91.6M	105.3M	110.6M
Interest Expense	153.3M	152.2M	(21.2M)	154.5M	177.7M	186.6M
Selling General Administrative	2.0B	2.6B	2.9B	3.2B	3.7B	3.9B
Total Revenue	20.3B	27.8B	33.5B	35.5B	40.8B	42.8B
Gross Profit	4.9B	7.9B	10.5B	9.4B	10.8B	11.3B
Other Operating Expenses	17.4B	22.5B	25.9B	29.4B	33.8B	35.5B
Operating Income	2.8B	5.3B	7.6B	6.4B	7.4B	7.8B
Ebit	2.8B	5.3B	7.6B	6.1B	7.0B	7.4B
Ebitda	2.9B	5.4B	7.7B	6.2B	7.1B	7.5B
Cost Of Revenue	15.4B	19.9B	23.0B	26.1B	30.0B	31.5B
Total Operating Expenses	2.0B	2.6B	2.9B	3.2B	3.7B	3.9B
Income Before Tax	3.0B	5.4B	7.6B	6.3B	7.3B	7.6B
Total Other Income Expense Net	152.4M	33.4M	59.3M	213.1M	245.1M	257.3M
Net Income	2.4B	4.2B	5.9B	4.7B	5.5B	5.7B
Income Tax Expense	602.5M	1.2B	1.7B	1.5B	1.7B	1.8B
Net Income Applicable To Common Shares	2.4B	4.2B	5.9B	4.7B	5.5B	5.7B
Net Income From Continuing Ops	2.4B	4.2B	5.9B	4.8B	5.5B	5.8B
Minority Interest	281.5M	(15.4M)	(38.1M)	(49.5M)	(56.9M)	(54.1M)
Tax Provision	602.5M	1.2B	1.7B	1.5B	1.7B	920.2M
Reconciled Depreciation	80.4M	73.9M	81.4M	91.6M	105.3M	81.1M

Pair Trading with DR Horton

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DR Horton position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DR Horton will appreciate offsetting losses from the drop in the long position's value.

Moving together with DHI Stock

0.85

Brunswick Earnings Call This Week

Pair Corr

Moving against DHI Stock

0.59	NKE	Nike Inc Financial Report 4th of July 2024	Pair Corr
0.54	VEEE	Twin Vee Powercats	Pair Corr
0.52	EWCZ	European Wax Center Financial Report 8th of May 2024	Pair Corr
0.5	WINA	Winmark	Pair Corr
0.49	EGOX	NexteGO NV Ordinary	Pair Corr

The ability to find closely correlated positions to DR Horton could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DR Horton when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DR Horton - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DR Horton to buy it.

The correlation of DR Horton is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DR Horton moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DR Horton moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for DR Horton can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:

How To Invest In DHI

Details

Is DHI Stock a good investment?

Details

What is DR Horton's Net Worth?

Details

Largest Household Durables Companies

View

Largest Consumer Durables & Apparel Companies

View

For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.

Note that the DR Horton information on this page should be used as a complementary analysis to other DR Horton's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for DHI Stock analysis

When running DR Horton's price analysis, check to measure DR Horton's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DR Horton is operating at the current time. Most of DR Horton's value examination focuses on studying past and present price action to predict the probability of DR Horton's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DR Horton's price. Additionally, you may evaluate how the addition of DR Horton to your portfolios can decrease your overall portfolio volatility.

	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Transaction History View history of all your transactions and understand their impact on performance
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges

Is DR Horton's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.022

Dividend Share

1.05

Earnings Share

13.87

Revenue Per Share

106.305

Quarterly Revenue Growth

0.065

The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

DHI Historical Income Statement

About DHI Income Statement Analysis

DR Horton Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

DR Horton income statement Correlations

DR Horton Account Relationship Matchups

High Positive Relationship

High Negative Relationship

DR Horton income statement Accounts

Pair Trading with DR Horton

Moving together with DHI Stock

Moving against DHI Stock

Complementary Tools for DHI Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Revenue	+ 1.0	Selling General Administrative
Other Operating Expenses	+ 1.0	Selling General Administrative
Cost Of Revenue	+ 1.0	Selling General Administrative
Total Operating Expenses	+ 1.0	Selling General Administrative
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue

Non Recurring	- 0.79	Depreciation And Amortization
Non Recurring	- 0.65	Selling And Marketing Expenses
Non Recurring	- 0.64	Total Operating Expenses
Non Recurring	- 0.64	Cost Of Revenue
Non Recurring	- 0.64	Other Operating Expenses
Non Recurring	- 0.64	Selling General Administrative